2 completed. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Thienopyridines: new trials by email Literature Review of Thienopyridines trials Research Report on Thienopyridines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aspirin Resistance and Percutaneous Coronary Intervention (PCI) Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina | Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 36 | 2007-04-01 | 2018-02-14 |
| Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention clopidogrel treatment after bare metal stent implantation, clopidogrel after zotarolimus-eluting stent implantation, clopidogrel after paclitaxel-eluting stent implantation - Coronary Artery Disease | Phase 4 | Completed | Marco Valgimigli | 1700 | 2006-12-01 | 2012-10-10 |
Angina, Stable (1) · Coronary Artery Disease (1) · Death (1) · Hemorrhage (1)
Icahn School of Medicine at Mount Sinai (1) · Marco Valgimigli (1)
Italy (1) · United States (1)
Annapoorna S Kini, MD MRCP (1) · Marco Valgimigli, MD, PhD (1)
PMID 21095265, PMID 22438530, PMID 23315904, PMID 24161321, PMID 24332420, PMID 25718355, PMID 26342472, PMID 26643501, PMID 26995375, PMID 27572001, PMID 28605779, PMID 29275371, PMID 35224730